Equity Overview
Price & Market Data
Price: $2.54
Daily Change: +$0.11 / 4.33%
Daily Range: $2.40 - $2.56
Market Cap: $139,758,778
Daily Volume: 114,722
Performance Metrics
1 Week: -1.96%
1 Month: 59.24%
3 Months: 52.80%
6 Months: 194.8%
1 Year: 122.8%
YTD: 90.84%
Company Details
Employees: 62
Sector: Health technology
Industry: Pharmaceuticals: major
Country:
Details
Connect Biopharma Holdings Limited, a clinical-stage biopharmaceutical company, engages in the development of therapies for the treatment of inflammatory diseases in the United States. The company's lead product candidate is rademikibart (formerly CBP-201), an antibody designed to target interleukin-4 receptor alpha, which is in Phase 3 studies for the treatment of inflammatory diseases such as atopic dermatitis and asthma. Connect Biopharma Holdings Limited was founded in 2012 and is headquartered in San Diego, California.